Status:
UNKNOWN
Adjuvant Chemotherapy in Patients With Lymph Node Metastasis After Radical Surgery in Cervical Cancer
Lead Sponsor:
Korean Gynecologic Oncology Group
Conditions:
Cervical Cancer
Eligibility:
FEMALE
20-70 years
Phase:
PHASE2
Brief Summary
Purpose Primary endpoint * To evaluate the 3-year disease free survival Second endpoints * To evaluate the 3-year \& 5-year overall survival To analyze the toxicity and the quality of life
Eligibility Criteria
Inclusion
- cervical cancer stage Ia2-IIa
- histology; squamous, adeno, adenosquamous subtype
- age; 20∼70 years
- performance status; GOG 0∼2
- no medical illness
- hematologic, renal, hepatic function; normal
- grossly no residual disease
- histologically confirmed lymph nodes metastases
- no parametrial extension and negative resection margin
- number of retrieved lymph nodes; ≥ 20
Exclusion
- patients with grade 2 peripheral neuropathy
- patients with uncontrolled infection
Key Trial Info
Start Date :
January 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
January 1 2015
Estimated Enrollment :
69 Patients enrolled
Trial Details
Trial ID
NCT01487226
Start Date
January 1 2008
End Date
January 1 2015
Last Update
December 7 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
KGOG
Seoul, South Korea